Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

Share Price is delayed by 15 minutes
Get Live Data
43.80    0.00 (0.00%)
Bid:
42.80
Ask:
44.80
Spread: 2.00 (4.673%)
Market Cap: £68.37m
MIG3 Live PriceLast checked at - London Stock Exchange

Intraday Maven Grwth 3 Share Chart

Dividend Declaration

6 Feb 2024 11:07

RNS Number : 1954C
Maven Income and Growth VCT 3 PLC
06 February 2024
 

 

Maven Income and Growth VCT 3 PLC

 

Proposed Final Dividend

 

On 18 December 2023, the Directors of Maven Income and Growth VCT 3 PLC ("the Company") announced that the unaudited net asset value of the Company as at 30 November 2023 was 52.48p per Ordinary Share.

 

The Directors propose that a final dividend of 2.15p per Ordinary Share, in respect of the year ended 30 November 2023, be paid on 3 May 2024 to Shareholders on the register at close of business on 22 March 2024.

 

As Shareholders will be aware from recent Annual and Interim Reports, decisions on distributions take into consideration a number of factors, including the availability of surplus revenue, the realisation of capital gains, the adequacy of distributable reserves and the VCT qualifying level. The Board and the Manager recognise the importance of tax-free distributions to Shareholders and, subject to the conditions set out above, will seek, as a guide, to pay an annual dividend that represents 5% of the NAV per share at the immediately preceding year end. This final dividend will bring total distributions for the financial year to 2.65p per Ordinary Share, representing an annual yield of 4.62%.

 

Since the Company's launch, and after receipt of this final dividend, a total of 99.72p per share will have been distributed in tax-free dividends. It should be noted that the effect of paying dividends is to reduce the NAV of the Company by the total cost of the distribution.

 

 

Dividend Investment Scheme

The Company has in place a Dividend Investment Scheme (DIS) through which Shareholders may elect to have their dividend payments used to apply for new Ordinary Shares issued by the Company under the standing authority requested from Shareholders at Annual General Meetings. Shares issued under the DIS should qualify for VCT tax reliefs applicable for the tax year in which they are allotted, subject to an individual Shareholder's particular circumstances. Terms & conditions of the scheme, together with a mandate form, are available from the Company's webpage at: mavencp.com/migvct3.

Shareholders who have not previously applied to participate in the DIS and who wish to do so in respect of the dividend payable on 3 May 2024, should ensure that a mandate form is received by the Company's Registrar, The City Partnership (UK) Limited, prior to the dividend election date of 12 April 2024. Election to participate in the DIS can also be made through the Registrar's online investor hub at: maven-cp.cityhub.uk.com.

 

Further to the information disclosed above, the Directors confirm that they are satisfied that all inside information (as defined by Article 7 of the Market Abuse Regulation (596/2014/EU)) that the Directors and the Company may have in their possession relating to the Company during the 30 day closed period leading up to the announcement of its annual results for the year ended 30 November 2023 has been or will be notified to a regulatory information service.

 

Issued on behalf of the Board

Maven Capital Partners UK LLP

Company Secretary

6 February 2024

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVEAFAKEELLEFA
Date   Source Headline
5th Apr 201312:17 pmRNSDirector/PDMR Shareholding
4th Apr 20135:35 pmRNSDirector/PDMR connected person shareholding
4th Apr 20134:07 pmRNSTransaction in Own Shares
27th Mar 20137:00 amRNSAnnual Financial Report
5th Mar 20134:13 pmRNSIssue of Equity
11th Feb 20135:42 pmRNSOffer for Subscription - Update
23rd Jan 20135:03 pmRNSIssue of Equity
16th Nov 20123:02 pmRNSTransaction in Own Shares
15th Nov 20125:01 pmRNSTransaction in Own Shares
14th Nov 20123:21 pmRNSTransaction in Own Shares
5th Nov 20125:01 pmRNSIssue of Equity
30th Oct 20127:00 amRNSTransaction in Own Shares
30th Oct 20127:00 amRNSTransaction in Own Shares
25th Oct 20127:00 amRNSDirector/PDMR Shareholding
23rd Oct 201210:02 amRNSDirector/PDMR Shareholding
19th Oct 20122:15 pmRNSInterim Management Statement
17th Oct 20125:20 pmRNSResult of General Meeting
21st Sep 20122:17 pmRNSCirc re. Enhanced Buyback Scheme
13th Sep 20121:03 pmRNSStatement re Enhanced Buyback Scheme
23rd Aug 20126:30 pmRNSDirector/PDMR Shareholding
16th Aug 20125:00 pmRNSDirector/PDMR Shareholding
6th Aug 201212:00 pmRNSTransaction in Own Shares
13th Jul 20124:59 pmRNSHalf Yearly Report
31st May 20125:14 pmRNSTransaction in Own Shares
25th May 201211:56 amRNSTransaction in Own Shares
25th May 201211:54 amRNSTransaction in Own Shares
23rd May 20122:29 pmRNSTransaction in Own Shares
22nd May 20125:12 pmRNSTransaction in Own Shares
4th May 20125:22 pmRNSDirector/PDMR Shareholding
4th May 201212:18 pmRNSAnnual Information Update
3rd May 201211:47 amRNSResult of AGM
1st May 20122:59 pmRNSInterim Management Statement
20th Apr 20121:31 pmRNSIssue of Equity
20th Apr 20121:09 pmRNSIssue of Equity
10th Apr 20129:48 amRNSIssue of Equity
27th Mar 201211:03 amRNSTransaction in Own Shares
23rd Mar 20124:55 pmRNSTransaction in Own Shares
20th Mar 201210:56 amRNSTransaction in Own Shares
19th Mar 201212:23 pmRNSTransaction in Own Shares
16th Mar 20124:43 pmRNSDirector/PDMR Shareholding
16th Mar 20123:05 pmRNSTransaction in Own Shares
13th Mar 201212:10 pmRNSAnnual Financial Report
8th Mar 201210:57 amRNSDirector/PDMR Shareholding
2nd Mar 20129:37 amRNSIssue of Equity
7th Dec 20114:22 pmRNSIssue of Equity
2nd Dec 20112:56 pmRNSTransaction in Own Shares
30th Nov 20114:26 pmRNSTransaction in Own Shares
28th Nov 20112:44 pmRNSTransaction in Own Shares
22nd Nov 20114:29 pmRNSTransaction in Own Shares
21st Nov 20114:56 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.